GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio Preventive Medicine Corp (ROCO:6810) » Definitions » Gross-Profit-to-Asset %

Bio Preventive Medicine (ROCO:6810) Gross-Profit-to-Asset % : 0.30% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Bio Preventive Medicine Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Bio Preventive Medicine's annualized Gross Profit for the quarter that ended in Dec. 2023 was NT$0.86 Mil. Bio Preventive Medicine's average Total Assets over the quarter that ended in Dec. 2023 was NT$283.82 Mil. Therefore, Bio Preventive Medicine's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 0.30%.


Bio Preventive Medicine Gross-Profit-to-Asset % Historical Data

The historical data trend for Bio Preventive Medicine's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio Preventive Medicine Gross-Profit-to-Asset % Chart

Bio Preventive Medicine Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial - - 0.41 0.91 0.40

Bio Preventive Medicine Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.92 1.11 0.89 0.45 0.30

Competitive Comparison of Bio Preventive Medicine's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Bio Preventive Medicine's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio Preventive Medicine's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio Preventive Medicine's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Bio Preventive Medicine's Gross-Profit-to-Asset % falls into.



Bio Preventive Medicine Gross-Profit-to-Asset % Calculation

Bio Preventive Medicine's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1.083/( (273.117+264.657)/ 2 )
=1.083/268.887
=0.40 %

Bio Preventive Medicine's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0.862/( (302.991+264.657)/ 2 )
=0.862/283.824
=0.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Bio Preventive Medicine Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Bio Preventive Medicine's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio Preventive Medicine (ROCO:6810) Business Description

Traded in Other Exchanges
N/A
Address
No.18, Taiyuan Street, 1 of 6th Floor, Hsinchu County, Zhubei, TWN, 30265
Bio Preventive Medicine Corp is an innovative clinical-staged biotech company, focusing on early detection and prevention of diseases specialty of those high value added molecular diagnostic product.

Bio Preventive Medicine (ROCO:6810) Headlines

No Headlines